Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses
AssigneeLacer, S.A.
InventorsJose Moliner, Eduardo Perez-Rasilla, Francisco Coy
Life of this patent
Estimating the term…
Abstract
In the present invention there are disclosed new derivatives of dianhydrohexite mononitrate corresponding to formula (I), tautomers, pharmaceutically acceptable salts, prodrugs and solvates thereof as well as pharmaceutical compositions comprising these compounds and uses thereof.
Claims24
A compound according to formula (I) or a tautomer, a pharmaceutically acceptable salt, a prodrug or a solvate thereof:
- wherein:
- n is an integer of 0, 1, or 2
- X represents —S(O)m—, —(C=═)— or a single bond, wherein m is an integer of 0, 1, or 2, with the proviso that when X represents —(C═O)—, then n is 0,
- R represents hydrogen or is a residue Ra, which residue Ra is selected from the group consisting of:
- C1-6 alkyl;
- C2-6 alkenyl;
- C3-8 cycloalkyl;
- C3-8 cycloalkyl, wherein one CH2 group is replaced by O, S, NH or NCH3;
- C4-8 cycloalkenyl;
- C4-8 cycloalkenyl, wherein one CH2 group is replaced by O, S, N or NCH3;
- phenyl;
- pyridyl;
- thiophenyl;
- nitrosyl;
- S-cysteinyl;
- S-glutathionyl;
- and
- wherein R* is selected from the group consisting of hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-8 cycloalkyl;
- C4-8 cycloalkenyl, acetyloxy, hydroxyl, ONO2 and halogen,
- wherein Ra optionally is substituted by one to three groups independently selectd from C1-6 alkyl, C2-6 alkenyl, C3-8 cycloalkyl, C4-8 cycloalkenyl, acetyloxy, hydroxyl, ONO2 and halogen,
- provided that when RXS(O)n—and —ONO2 are trans to each other with respect to the ring plane as depicted in formulae (Ia) and (Ib):
- then RXS(O)n— does not represent
- wherein Z is an C1-C4 alkyl group, aryl group, or an aralkyl group.
18-33. (canceled)
A process for preparing a compound of formula (I), a tautomer, a pharmaceutically acceptable salt, a prodrug or a solvate thereof:
- wherein:
- n is an integer of 0, 1, or 2,
- X represents —S(O)m— or a single bond, wherein m is an integer of 0, 1, or 2,
- and R represents hydrogen or is a residue Ra, which residue Ra is selected from the group consisting of:
- C1-6 alkyl;
- C2-6 alkenyl;
- C3-8 cycloalkyl;
- C3-8 cycloalkyl, wherein one CH2 group is replaced by O, S, N or NCH3;
- C4-8 cycloalkenyl;
- C4-8 cycloalkenyl, wherein one CH2 group is replaced by O, S, N or NCH3;
- phenyl;
- pyridyl;
- thiophenyl;
- nitrosyl;
- S-cysteinyl;
- S-glutathionyl;
- and
- wherein R* is selected from the group consisting of hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-8 cycloalkyl;
- C4-8 cycloalkenyl, acetyloxy, hydroxyl, ONO2 and halogen,
- wherein Ra optionally is substituted by one to three groups independently selected from the group consisting of C1-6 alkyl, C2-6 alkeny, C3-8 cycloalkyl, C4-8 cycloalkenyl, acetyloxy, hydroxyl, ONO2 and halogen, which process comprises conducting the following steps:
- a) effecting the hydrolysis of a compound of formula (IIa):
- wherein R′ is C1-C6 alkyl, preferably methyl,
- to obtain the following compound:
- and
- (b) optionally, effecting on the compound prepared according to the step (a):
- I. an oxidation reaction to obtain:
- optionally followed by a second oxidation to obtain the following compound:
- wherein:
- n is 1 or 2,
- X is —S(O)m—, wherein m is 0, 1 or 2, and
- R* represents hydroxyl or ONO2;
- II. a substitution reaction to obtain:
- a compound according to formula (I), wherein:
- n is an integer of 0,
- X represents a bond,
- and R does not represent nitrosyl,
- optionally followed by an oxidation to obtain a compound according to formula (I), wherein:
- n is an integer of 0,
- X represents —S(O)m—, wherein m is an integer of 0 or 1,
- and R does not represent nitrosyl;
- III. a substitution reaction to obtain:
- a compound according to formula (I), wherein:
- n is an integer of 0, and
- X represents —S—;
- optionally followed by an oxidation to obtain a compound according to formula (I), wherein:
- n is an integer of 1 or 2, and
- X represents —S(O)m—, wherein m is 0, 1 or 2;
- or
- IV. a nitrosation reaction to obtain:
A process for preparing a compound of formula (11) or a tautomer, a pharmaceutically acceptable salt, a prodrug or a solvate thereof:
- which process comprises the following steps:
- a) effecting an oxidation of a compound of formula (III):
- wherein R′ is C1-C6 alkyl, preferably methyl, to obtain 2,2′-dithiodiisosorbide (10),
- and
- (b) effecting a nitration of the compound prepared in step (a) with a nitrating agent in the presence of a carboxylic anhydride, preferably acetic anhydride.
2,2′-dithiodiisosorbide.
Dependencies are inferred from the claim text.